Drugs by condition
Drugs approved for high cholesterol
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
74
Still marketed, NDA or BLA
Drug classes
13
Novel drugs
30
New molecular entities and new biologics
In development
26
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for high cholesterol.
- Qlonilik (Clonidine Hydrochloride) · Cmp Dev LLC Jul 29, 2026
- Lipfendra (Enlicitide Decanoate) · Msd NovelPriority reviewJul 15, 2026
- Baxfendy (Baxdrostat) · Astrazeneca Ab NovelPriority reviewMay 15, 2026
- Lerochol (Lerodalcibep-Liga) · Lib Therapeutics, Inc. NovelDec 12, 2025
- Javadin (Clonidine Hydrochloride) · Azurity Oct 23, 2025
All approved drugs for high cholesterol, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 541 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Thiazide Diuretic (9)
- Inzirqo Hydrochlorothiazide · Novitium Pharma · 2025
- Tribenzor Amlodipine Besylate, Hydrochlorothiazide, Olmesartan Medoxomil · Cosette · 2010
- Exforge Hct Amlodipine Besylate, Hydrochlorothiazide, Valsartan · Novartis · 2009
- Benicar Hct Hydrochlorothiazide, Olmesartan Medoxomil · Cosette · 2003
- Micardis Hct Hydrochlorothiazide, Telmisartan · Boehringer Ingelheim · 2000
- Atacand Hct Candesartan Cilexetil, Hydrochlorothiazide · Ani Pharms · 2000
- Diovan Hct Hydrochlorothiazide, Valsartan · Novartis · 1998
- Hyzaar Hydrochlorothiazide, Losartan Potassium · Organon · 1995
- Zestoretic Hydrochlorothiazide, Lisinopril · Almatica · 1989
Aldosterone Antagonist (4)
- Inspra Eplerenone · Upjohn · 2002
- Aldactone Spironolactone · Pfizer · 1960
- Carospir Spironolactone · Cmp Dev LLC · 2017
- Aldactazide Hydrochlorothiazide, Spironolactone · Pfizer · 1961
Angiotensin 2 Receptor Blocker (4)
- Avapro Irbesartan · Sanofi Aventis US · 1997
- Prexxartan Valsartan · Carmel Biosciences · 2017
- Exforge Amlodipine Besylate, Valsartan · Novartis · 2007
- Diovan Valsartan · Novartis · 2001
Thiazide-like Diuretic (3)
- Hemiclor Chlorthalidone · Prm Pharma · 2025
- Edarbyclor Azilsartan Kamedoxomil, Chlorthalidone · Azurity · 2011
- Thalitone Chlorthalidone · Casper Pharma LLC · 1988
Adenosine Triphosphate-Citrate Lyase Inhibitor (2)
PCSK9 Inhibitor (2)
HMG-CoA Reductase Inhibitor (2)
Dihydropyridine Calcium Channel Blocker (2)
- Norliqva Amlodipine Besylate · Cmp Dev LLC · 2022
- Procardia Xl Nifedipine · Pfizer · 1989
Endothelin Receptor Antagonist (1)
- Tryvio Aprocitentan · Idorsia · 2024
beta-Adrenergic Blocker (1)
- Tenormin Atenolol · Twi Pharms · 1981
Peroxisome Proliferator Receptor alpha Agonist (1)
- Antara (Micronized) Fenofibrate · Lupin · 2004
Dietary Cholesterol Absorption Inhibitor (1)
- Vytorin Ezetimibe, Simvastatin · Organon · 2004
Class not listed in FDA's data (42)
- Lipfendra Enlicitide Decanoate · Msd · 2026
- Baxfendy Baxdrostat · Astrazeneca Ab · 2026
- Lerochol Lerodalcibep-Liga · Lib Therapeutics, Inc. · 2025
- Leqvio Inclisiran Sodium · Novartis · 2021
- Juxtapid Lomitapide Mesylate · Chiesi · 2012
- Edarbi Azilsartan Kamedoxomil · Azurity · 2011
- Livalo Pitavastatin Calcium · Kowa CO · 2009
- Bystolic Nebivolol Hydrochloride · Allergan · 2007
- Tekturna Aliskiren Hemifumarate · Lxo Ireland · 2007
- Crestor Rosuvastatin Calcium · Astrazeneca · 2003
- Benicar Olmesartan Medoxomil · Cosette · 2002
- Welchol Colesevelam Hydrochloride · Cosette · 2000
- Atacand Candesartan Cilexetil · Ani Pharms · 1998
- Lipitor Atorvastatin Calcium · Upjohn · 1996
- Cozaar Losartan Potassium · Organon · 1995
- Norvasc Amlodipine Besylate · Viatris · 1992
- Lotensin Benazepril Hydrochloride · Validus Pharms · 1991
- Cardura Doxazosin Mesylate · Viatris · 1990
- Lopressor Metoprolol Tartrate · Validus Pharms · 1978
- Colestid Colestipol Hydrochloride · Pfizer · 1977
- Minipress Prazosin Hydrochloride · Pfizer · 1976
- Qlonilik Clonidine Hydrochloride · Cmp Dev LLC · 2026
- Javadin Clonidine Hydrochloride · Azurity · 2025
- Sdamlo Amlodipine Besylate · Brillian Pharma · 2025
- Lopressor Metoprolol Tartrate · Rubicon Research · 2025
- Arbli Losartan Potassium · Scienture · 2025
- Atorvaliq Atorvastatin Calcium · Cmp Dev LLC · 2023
- Katerzia Amlodipine Benzoate · Azurity · 2019
- Kapspargo Sprinkle Metoprolol Succinate · Spil · 2018
- Epaned Enalapril Maleate · Azurity · 2016
- Qbrelis Lisinopril · Azurity · 2016
- Azor Amlodipine Besylate, Olmesartan Medoxomil · Cosette · 2007
- Caduet Amlodipine Besylate, Atorvastatin Calcium · Pharmacia · 2004
- Innopran Xl Propranolol Hydrochloride · Ani Pharms · 2003
- Cardizem La Diltiazem Hydrochloride · Bausch · 2003
- Lescol Xl Fluvastatin Sodium · Sandoz · 2000
- Verelan Pm Verapamil Hydrochloride · Azurity · 1998
- Colestid Colestipol Hydrochloride · Pfizer · 1994
- Toprol-Xl Metoprolol Succinate · Melinta Therap · 1992
- Verelan Verapamil Hydrochloride · Azurity · 1990
- Zestril Lisinopril · Twi Pharms · 1988
- Phendimetrazine Tartrate Phendimetrazine Tartrate · Acertis Pharms · 1979
Drugs in development for high cholesterol
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- SHR-1918Phase 37 trials
Beijing Suncadia Pharmaceuticals Co., Ltd · Homozygous Familial Hypercholesterolemia, Hyperlipidemia, Hypercholesterolemia
- QLC7401Phase 34 trials
Qilu Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia or Mixed Hyperlipidemia, Heterozygous Familial Hypercholesterolemia (HeFH)
- SYH2053Phase 34 trials
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Non-familial Hypercholesterolemia and Mixed Hyperlipidemia, Heterozygous Familial Hypercholesterolemia (HeFH), Hypercholesterolemia and Mixed Hyperlipidemia
- ZodasiranAROANG3, VSA003Phase 33 trials
Arrowhead Pharmaceuticals · Homozygous Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia (HoFH)
- SAL003Phase 32 trials
Shenzhen Salubris Pharmaceuticals Co., Ltd. · Hyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemia, Hyperlipidemias
- AD-2281Phase 31 trial
Addpharma Inc. · Primary Hypercholesterolemia
- AD-2282Phase 31 trial
Addpharma Inc. · Primary Hypercholesterolemia
- AG2304RPhase 31 trial
Ahn-Gook Pharmaceuticals Co.,Ltd · Hypercholesterolemia
- AG2304TPhase 31 trial
Ahn-Gook Pharmaceuticals Co.,Ltd · Hypercholesterolemia
- BR1018APhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018A-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018BPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018B-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018CPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018C-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- DW5421APhase 31 trial
Daewon Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia, Mixed Dyslipidemia
- DW5421BPhase 31 trial
Daewon Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia, Mixed Dyslipidemia
- FDC laroprovstatPhase 31 trial
AstraZeneca · Hypercholesterolemia
- IBI306Phase 31 trial
Innovent Biologics (Suzhou) Co. Ltd. · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
- EDP167Phase 22 trials
Eddingpharm (Zhuhai) Co., Ltd. · Mixed Dyslipidemia, Homozygous Familial Hypercholesterolemia (HoFH)
4 discontinued brand-name drugs whose label still names it
More on high cholesterol: recruiting trials · published research
Related in cardiovascular and metabolic: Type 2 diabetes · Type 1 diabetes · Obesity and weight management · High blood pressure (hypertension) · Heart failure · High triglycerides · Atrial fibrillation · Blood clots (DVT and pulmonary embolism) · Stroke prevention · Coronary artery disease and heart attack
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.